Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
12.48
+0.50 (4.17%)
Jun 23, 2026, 3:00 PM CST
Market Cap5.04B +0.4%
Revenue (ttm)699.33M +33.8%
Net Income-27.51M
EPS-0.07
Shares Out 420.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,000,390
Open11.88
Previous Close11.98
Day's Range11.88 - 12.74
52-Week Range11.60 - 22.55
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 735
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.

Financial Statements